Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study
Maturitas · 2026
DOI: 10.1016/j.maturitas.2026.108886 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Maturitas, 2026. Verfasst von Tamar A Gootzen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands. Electronic address: tamar.gootze…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Fallopian Tube Neoplasms, Heart Disease Risk Factors, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Cancer Society.
Abstract (Originalsprache)
OBJECTIVES: The effects of risk-reducing salpingo-oophorectomy on the development of cardiovascular risk factors in women with BRCA1/2 pathogenic variants are unknown. We compared the development of cardiovascular risk factors 5 years post-surgery between participants who had risk-reducing salpingo-oophorectomy with and without hormonal replacement therapy and participants who had risk-reducing salpingectomy. STUDY DESIGN: Eligible participants with a BRCA1/2 pathogenic variant from the TUBA study were longitudinally followed and categorized into three groups: (1) salpingectomy without subsequent oophorectomy within 5 years, (2) salpingo-oophorectomy with hormonal replacement therapy (use ≥3 years), (3) salpingo-oophorectomy without hormonal replacement therapy (use
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands. Electronic address: tamar.gootzen@radboudumc.nl.
- IQ Health, Radboudumc, Kapittelweg 54, 6525 EP, Nijmegen, the Netherlands. Electronic address: marleen.vangelder@radboudumc.nl.
- IQ Health, Radboudumc, Kapittelweg 54, 6525 EP, Nijmegen, the Netherlands. Electronic address: rosella.hermens@radboudumc.nl.
- Department of Gynaecology and Obstetrics, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands. Electronic address: majke.vanbommel@radboudumc.nl.
- Department of Obstetrics and Gynecology, Medical Centre Leeuwarden, Thialfweg 44, 8441 PW, Leeuwarden, the Netherlands. Electronic address: mirjam.apperloo@mcl.nl.
- Department of Gynaecology and Obstetrics, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands. Electronic address: Marieke.arts-dejong@radboudumc.nl.
Förderung
- Dutch Cancer Society
Zitieren
APA
Gootzen, T. A., van Gelder, M. M. H. J., Hermens, R. P. M. G., van Bommel, M. H. D., Apperloo, M. J. A., Arts-de Jong, M., Zanten, M. M. A. B., Coppus, S. F. P. J., Custers, J., van Doorn, H. C., Gaarenstroom, K. N., Harmsen, M. G., Knippenberg, M., van Lonkhuijzen, L. R. C. W., Piek, J. M. J., Simons, M., Slangen, B. F. M., Tros, R., Vos, M. C., …, & de Hullu, J. A. (2026). Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study. Maturitas. https://doi.org/10.1016/j.maturitas.2026.108886
Vancouver
Gootzen TA, van Gelder MMHJ, Hermens RPMG, van Bommel MHD, Apperloo MJA, Arts-de Jong M, et al. Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study. Maturitas. 2026. doi:10.1016/j.maturitas.2026.108886
BibTeX
@article{Gootzen2026,
author = {Gootzen, Tamar A and van Gelder, Marleen M H J and Hermens, Rosella P M G and van Bommel, Majke H D and Apperloo, Mirjam J A and Arts-de Jong, Marieke and Zanten, Monique M A Brood-van and Coppus, Sjors F P J and Custers, Jose and van Doorn, Helena C and Gaarenstroom, Katja N and Harmsen, Marline G and Knippenberg, Marjan and van Lonkhuijzen, Luc R C W and Piek, Jurgen M J and Simons, Michiel and Slangen, Brigitte F M and Tros, Rachel and Vos, M Caroline and Yigit, Refika and Zweemer, Ronald P and Hoogerbrugge, Nicoline and Kets, C Marleen and Maas, Angela H E M and Steenbeek, Miranda P and de Hullu, Joanne A},
title = {Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study},
journal = {Maturitas},
year = {2026},
doi = {10.1016/j.maturitas.2026.108886}
}
EUVIMED